Tonic water gets its bitter flavor from quinine, a compound the Food and Drug Administration regulates as a food additive. Quinine also has a documented history in toxicology literature as a substance that has been reported to interfere with opiate immunoassay screening, the rapid first step most drug testing programs use before a lab confirms any result. This post explains how much quinine is actually in a glass of tonic water, what a screening immunoassay is designed to detect, what happens when a screen reads positive, and why a single ingredient in a mixed drink almost never survives lab confirmation as an actual opiate.
What is in tonic water
Quinine is a plant alkaloid originally derived from cinchona bark. The FDA permits quinine, as the hydrochloride or sulfate salt, to be added to carbonated beverages as a flavoring agent, and it caps the amount at 83 parts per million in the finished beverage. The regulation also requires that the label disclose the presence of quinine, which is why tonic water almost always says "quinine" somewhere on the bottle. This limit and labeling rule are set out in the FDA's food additive regulations on quinine as a food additive on the Electronic Code of Federal Regulations.
Eighty three parts per million works out to a small fraction of the quinine dose once used medically to treat malaria or, more recently, nighttime leg cramps, a use the FDA has separately warned against because of quinine's cardiac and blood disorder risks at therapeutic doses. A typical serving of tonic water delivers a small amount of quinine compared with a prescription tablet, not a clinical dose.
What the research says about opiate screens
Standard urine opiate immunoassays are built to react with morphine, codeine, and structurally related opioids. They are not built to detect quinine, and quinine is not an opioid. That said, immunoassay antibodies are not perfectly selective, and a review of toxicology testing pitfalls published through the National Library of Medicine's PubMed Central database lists quinine among several substances, alongside dextromethorphan, diphenhydramine, certain quinolone antibiotics, rifampin, verapamil, and poppy seeds, that have reportedly caused false positive opiate immunoassay results in some assay formulations. That source is available through the National Institutes of Health at Buyer Beware: Pitfalls in Toxicology Laboratory Testing.
This is reported cross reactivity, not a promise. Cross reactivity in an immunoassay depends on the specific antibody the manufacturer uses, the cutoff concentration the program sets, and the concentration of quinine actually present in the specimen. At the trace levels permitted in a carbonated beverage, there is limited published evidence that a normal serving of tonic water pushes urine quinine high enough to trigger a screen on its own. Program administrators and donors should treat this as a possible, low probability interference rather than an expected outcome.
Quinine's other role in drug testing
Quinine shows up in toxicology literature for two other reasons that are worth separating from the tonic water question. First, researchers have studied low dose quinine as an additive that can be measured in urine to confirm a patient actually took a prescribed opioid, a medication adherence approach described in a pharmacokinetic study published through PubMed Central on quinine as a potential adherence tracer when combined with oxycodone. Second, quinine has a long history as a cutting agent mixed into illicit heroin, which is a separate issue from beverage consumption. A case report published through PubMed Central on quinine co-injected with heroin notes that adulterants cut into street heroin are common and are often not detected by standard urine toxicology screening at all. In other words, quinine mixed into heroin is a medical and forensic issue tied to actual opioid use, not evidence that drinking a cocktail with tonic water puts opiates in anyone's system.
| Step | What it does | What it cannot do |
|---|---|---|
| Immunoassay screen (cup, dip card, or lab screen) | Flags specimens where an antibody reacts above a set cutoff, in minutes to hours | Identify the exact substance by name or distinguish quinine from an actual opioid |
| GC/MS or LC/MS confirmation | Separates and identifies individual molecules, reports a specific drug and concentration | N/A, this is the identification step |
| Medical review officer review | Compares the confirmed result against prescriptions and medical explanations before any result is reported to an employer | Override a confirmed positive without a legitimate medical explanation |
Why confirmation testing matters here
A presumptive positive on an immunoassay screen is not a final result on any program that follows standard practice. A non-negative screen is sent for confirmation by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry, methods that separate and identify individual compounds rather than relying on an antibody reaction. Confirmation testing distinguishes quinine from morphine, codeine, or any other opiate by molecular identity, not by a reaction pattern. If tonic water or any other quinine source caused a presumptive opiate screen, confirmation should not identify an actual opiate unless one is truly present in the specimen.
Federal workplace testing rules build this distinction into the process. Under Department of Transportation drug testing regulations, a laboratory confirmed result still goes to a medical review officer, a licensed physician who reviews the lab data and interviews the donor about prescriptions and other legitimate explanations before any result is reported to an employer. Those review duties are set out in 49 CFR Part 40, Subpart G, which governs medical review officer verification. A donor who believes a beverage, medication, or supplement affected a screen should raise it with the medical review officer and be ready to document what was consumed, rather than assuming the screen itself is the final word.
What employers and testers should do
Programs that see an unexpected non-negative opiate screen should not treat it as a confirmed drug finding and should not share a screen only result with a supervisor or make an employment decision on it. The specimen should go to confirmation, and any donor explanation, including a recent drink, a medication, or a supplement, should be documented and given to the medical review officer for review alongside the lab data. This keeps the process defensible and keeps the employer out of the business of interpreting chemistry it is not equipped to interpret.
Programs that want a lower false positive rate on initial screening can choose panels and cutoffs with input from their testing provider, and can stock confirmation-ready collection devices so a non-negative screen does not require a second visit. American Screening Corporation supplies dip cards, cups, and oral fluid devices for employer and clinic programs through its drug test cup collection. For context on how a presumptive screen differs from a verified result, see What Does Presumptive Positive Mean on a Drug Test. Rifampin is another substance in the same reported cross reactivity list discussed above, covered in more detail in Does Rifampin Cause a False Positive Drug Test. Businesses that want to stock testing supplies in volume can set up an account through the wholesale portal.
Foods and drinks with documented drug test questions
| Item | Compound involved | Panel typically asked about | What the evidence generally shows |
|---|---|---|---|
| Tonic water | Quinine | Opiate | Reported in some cross reactivity literature; trace beverage levels, limited published evidence of real world screen failures from normal servings |
| Poppy seed baked goods | Trace morphine and codeine residue on the seed | Opiate | Well documented; large servings can produce a true positive screen that confirmation can still resolve against dose and timing |
| Energy drinks | Caffeine, taurine | Amphetamine | Not a recognized cause of true amphetamine cross reactivity on standard immunoassays |
| Hemp or CBD labeled foods | Residual THC | THC | Depends on actual THC content of the product, not the hemp label alone |
| Quinine water used with prescribed opioids | Quinine as an adherence additive | Opiate monitoring programs | Studied as an intentional tracer, not a beverage interference question |
Frequently asked questions
Will drinking tonic water make me fail a drug test?
It is unlikely at normal beverage consumption levels. Quinine is capped at 83 parts per million in carbonated beverages under FDA rules, and there is limited published evidence that this trace amount pushes a screening immunoassay over a standard cutoff. A small number of older cross reactivity reports exist, so it is not impossible on every assay, but a confirmed opiate finding should not result from tonic water alone.
Is quinine itself an opiate?
No. Quinine is a plant alkaloid historically used as an antimalarial. It has no pharmacological relationship to morphine, codeine, or other opioids, and GC/MS or LC/MS confirmation testing identifies it as a distinct molecule, separate from any opiate.
Why does quinine sometimes get mentioned with heroin?
Quinine has a documented history as a cutting agent mixed into illicit heroin. Case reports describe quinine or quinidine causing medical complications in people who injected adulterated heroin, which is a toxicology issue tied to actual drug use, not a reason to expect a beverage to trigger a false result.
What happens if my opiate screen comes back non-negative?
A non-negative screen is a presumptive result, not a final one. It goes to laboratory confirmation by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry, and a medical review officer reviews the confirmed result along with any prescriptions or explanations the donor provides before anything is reported to an employer.
Should I tell the medical review officer I drank tonic water?
Yes. If a screen comes back non-negative and you believe a beverage, medication, or supplement may be a factor, document what you consumed and raise it during the medical review officer interview. The medical review officer's job is to compare that information against the confirmed lab result, not to accept or reject a claim without reviewing the data.
Does this mean all quinine sources are the same for drug testing purposes?
No. A trace amount in a carbonated beverage is not the same exposure as a therapeutic quinine dose or an adherence monitoring protocol that intentionally adds quinine to a medication. Dosing and medical use of quinine should be directed to a physician or pharmacist, not inferred from a beverage label.
This article is general information, not legal or medical advice. Testing programs should confirm requirements with qualified counsel and a licensed medical review officer.
